Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has appointed Dr. Bill Marathias as vice president of Business Development for the US to assist with the company’s international growth plans.   Sygnature Discovery already has a growing client base in the US, and is looking to expand this further. Bill will play an instrumental part of this expansion, working with colleague Dr. Bruce Sargent, drawing on their combined experien...